Search

Search Constraints

You searched for: Author/Creator Ohmachi, Ken

Search Results

1. 9p24.1 Genetic Alteration and PD-L1 Expression Are Characteristic of De Novo and Methotrexate-associated Epstein-Barr Virus–positive Hodgkin Lymphoma, But Not Methotrexate-associated Hodgkin-like Lesions. (18th August 2022)

2. Clinical outcome of Epstein–Barr virus‐positive diffuse large B‐cell lymphoma of the elderly in the rituximab era. Issue 9 (8th September 2014)

3. Clinicopathological analysis of follicular lymphoma with BCL2, BCL6, and MYC rearrangements. Issue 6 (17th March 2022)

6. Phase I study of tirabrutinib (ONO‐4059/GS‐4059) in patients with relapsed or refractory B‐cell malignancies in Japan. Issue 5 (28th March 2019)

7. Prognostic model for mantle cell lymphoma in the rituximab era: a nationwide study in Japan. (7th May 2015)

8. R‐High‐CHOP/CHASER/LEED with autologous stem cell transplantation in newly diagnosed mantle cell lymphoma: JCOG0406 STUDY. Issue 9 (28th July 2018)

9. Single response assessment of transplant-ineligible multiple myeloma: a supplementary analysis of JCOG1105 (JCOG1105S1). (6th May 2021)